High frequency of increased triclosan MIC among CC5 MRSA and risk of misclassification of the SCCmec into types.

Journal Information

Full Title: J Antimicrob Chemother

Abbreviation: J Antimicrob Chemother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Transparency declarations: There are no conflicts of interest to declare."

Evidence found in paper:

"Funding This work was supported in part by: the National Institutes of Health (NIH) # 1R01AI137526-01 to P.J.P.; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 307672/2019-0 to A.M.S.F.; Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) #E-26/210.193/2014 to A.M.S.F. and P.J.P. and #E-26/010.001280/2016, #E-26.202.803/2017, #E-26/211.554/2019 and #E-26/010.002435/2019 to A.M.S.F; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) #001 to A.M.S.F. and A.S.V.; and Bill & Melinda Gates Foundation # OPP1193112 and the Brazilian Minister of Health/DECIT/CNPq # 443804/2018-4 to A.M.S.F. Under the grant condition of the Foundation, a Creative Commons Attribution 4.0 Generic Licence has already been signed to the Author Accepted Manuscript version that might arise from this submission. A.S.V. was awarded with PhD fellowships from CNPq #140774/2019-0 and FAPERJ # E-26/201.676/2021."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025